Navigation Links
DePuy Hip Class I Recall Announced By FDA of Its DePuy LPS Lower Extremity Dovetail Intercalary Hip Implant Component Due to Risk of Fracturing, Reports Wright & Schulte
Date:8/4/2013

Columbus, OH (PRWEB) August 05, 2013

The Food and Drug Administration (FDA) has recently announced that DePuy Orthopaedics, Inc. has issued an Urgent Medical Device Recall for one of its popular hip implant components, the LPS Lower Extremity Dovetail Intercalary component. This DePuy recall has been issued due to the component’s propensity to fracture. While DePuy issued its recall of this component on July 11, 2013, as of August 1, 2013, the FDA elevated this DePuy recall to a Class I recall status – the most serious type of recall that can be issued – due to the likelihood of alleged serious injury or death associated with these malfunctioning DePuy hip implant components.

According to the FDA’s DePuy recall announcement, the recalled LPS hip implant component can fracture under “normal physiologic loads while walking.” This means that it does not take a lot of weight on these components in order to increase the likelihood that they will break. Patients with the highest risk of experiencing an LPS hip implant fracture include those who weigh more than 200 pounds and/or who are highly active individuals.

In the event that the LPS Lower Extremity Dovetail Intercalary component does fracture, patients will likely experience severe hip pain and immediate loss of hip function. In most cases of the component fracturing, patients will need to undergo risky revision surgery to remove the broken component. Additionally, patients who experience a component fracture will typically also suffer from serious nerve injuries and may even lose the leg connected to the fractured device.
[fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm363505.htm August 2013]

Wright & Schulte, LLC is an experienced product liability law firmv defending the rights of those who have sustained serious injuries after using defective products. We encourage those who believe they have sustained DePuy hip implant complications to speak with our knowledgeable lawyers by visiting yourlegalhelp.com or by calling 1-800-399-0795.

As part of this DePuy hip implant recall, DePuy is providing medical professionals with a template letter to help them notify their patients who may be at risk of a component fracture, as well as to inform patients about the possible signs that a component fracture has taken place. Additionally, medical professionals and distributors have been warned to immediately stop using the recalled lots of the LPS components, which include 130896, 132131, 132133, 209461, 209466, 219843, 232972, 295965, 310189, 336843, 349283, 352878, 374125, 379089, A1TAR1 and A2AGN1. While DePuy has not recommended revision surgery or extensive follow-up medical care for patients who are not displaying symptoms of a possible component fracture, for those who are, DePuy recommends immediate medical care to prevent patients from developing potentially life-threatening complications.
[fda.gov/MedicalDevices/Safety/ListofRecalls/ucm363452.htm August 2013]

This is not the first DePuy Hip recall. In August 2010, DePuy voluntarily recalled its Metal-On-Metal ASR hip implants due to reports from the National Joint Registry of England and Wales that these devices had a failure rate of about 13 percent within five years of the DePuy Hip implantation. In 2011, however, this registry updated its findings on DePuy ASR hip implants, warning the public that more than 33 percent of DePuy ASR hip implants would fail within five years of implantation. [nytimes.com/2013/01/23/business/jj-study-suggested-hip-device-could-fail-in-thousands-more.html?_r=1& January 2013]

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Read the full story at http://www.prweb.com/releases/2013/8/prweb10962655.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes DePuy Orthopaedic’s Motion for Summary Judgment in California Bellwether Case
2. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy Pinnacle Hip Litigation
3. US Drug Watchdog Now Urges All DePuy ASR Recalled Metal Hip Implant Recipients In The Remaining States To Call Them Immediately If They Have Not Yet Been Identified
4. US Drug Watchdog Now Warns Recipients Of A Recalled DePuy ASR Hip Implant About Statute Of Limitations Deadline To Get Identified And Urges Recipients To Call Them
5. California Judge Allows Plaintiffs in DePuy ASR Litigation to Combine DePuy Pinnacle Claims, Parker Waichman LLP Notes
6. DePuy Hip Replacement Lawsuit News: California Judge Allows DePuy ASR Lawsuit Plaintiffs to Add Pinnacle Hip Claims
7. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Call Them About A Vital Blood Test That Should Reveal A Premature Failure
8. US Drug Watchdog Now Urges All DePuy Pinnacle All Metal Hip Implant Recipients To Call Them For The Name Of A Special Blood Test That Will Determine A Premature Failure
9. US Drug Watchdog Now Urges All DePuy Pinnacle All Metal Hip Implant Recipients To Call Them About A Specific Blood Test Designed To Determine A Failure-Nationwide
10. DePuy Pinnacle Lawsuit Filed by Wright & Schulte on Behalf of Utah Man Who Developed Serious Injuries Allegedly Due to the DePuy Pinnacle Metal on Metal Hip Replacement
11. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Canadian Report That Shows Some Metal-on-Metal Hip Recipients More Likely to Need Revision Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: